您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报 (医学版) ›› 2020, Vol. 58 ›› Issue (1): 73-76.doi: 10.6040/j.issn.1671-7554.0.2019.1160

• • 上一篇    

后肾腺瘤的诊断和治疗:单中心经验

雷坤阳1,王旭2,马明1,孙庭1   

  1. 南昌大学第一附属医院 1. 泌尿外科;2. 病理科, 江西 南昌 330000
  • 发布日期:2022-09-27
  • 通讯作者: 孙庭. E-mail:doctorsunting1960@163.com

Diagnosis and treatment of matanephric adenoma: a single center experience

LEI Kunyang1, WANG Xu2, MA Ming1, SUN Ting1   

  1. 1. Department of Urology;
    2. Department of Pathology, The First Affiliated Hospital of Nanchang University, Nanchang 330000, Jiangxi, China
  • Published:2022-09-27

摘要: 目的 探讨后肾腺瘤(MA)的临床表现、影像学特点、病理学特征、治疗方法和预后,以提高对MA的诊断和治疗水平。 方法 回顾性分析南昌大学第一附属医院自2011年5月至2019年1月收治的经病理学确诊的9例MA患者的临床资料,对其临床表现、影像学特点、组织学和免疫组化特征、治疗方法以及预后进行总结、分析和讨论。 结果 本组9例,其中腰痛者1例,腰部不适者2例,腰痛合并红细胞增多症1例,其余5例均为体检发现;肿瘤位于左侧5例,右侧4例;肿瘤平均直径为4.3(1.7~6.7)cm;行腹腔镜肾部分切除术(LPN)者7例,行腹腔镜根治性肾切除术(LRN)者2例;所有患者术后病理诊断均为MA;平均随访时间为43(5~97)个月,患者均无复发或转移征象。 结论 MA是一种罕见的肾脏肿瘤,临床表现和影像学特征对诊断有一定帮助,确诊主要依赖病理学,预后一般良好,但需定期随访。

关键词: 后肾腺瘤, 病理学, 诊断, 治疗

Abstract: Objective To explore the clinical manifestations, imaging features, pathological features, treatment and prognosis of metanephric adenoma(MA)in order to improve the diagnosis and treatment of MA. Methods The clinical data of 9 MA patients confirmed by pathology in The First Affiliated Hospital of Nanchang University from May 2011 to January 2019 were analyzed retrospectively, and their clinical manifestations, imaging characteristics, histological and immunohistochemical characteristics, treatment methods and prognosis were summarized, analyzed and discussed. Results A total of 9 MA patients were enroued in this study, including 1 case of low back pain, 2 cases of low back discomfort, 1 case of low back pain complicated with polycythemia, and the other 5 cases were found by physical examination. The tumors were located on the left side in 5 cases and on the right side in 4 cases. The mean diameter of the tumors was 4.3(1.7-6.7)cm. Laparoscopic partial nephrectomy(LPN)was performed in 7 cases and laparoscopic radical nephrectomy(LRN)in 2 cases. All cases were pathologically diagnosed as MA. The mean follow-up time was 43(5-97)months, and there were no recurrence or metastasis in all cases. Conclusion MA is a rare renal tumor. Its clinical manifestations and imaging features are helpful for diagnosis, but the diagnosis mainly depends on pathology. The prognosis of MA is generally good, but regular follow-up is needed.

Key words: Matanephric adenoma, Pathology, Diagnosis, Treatment

中图分类号: 

  • R602
[1] Wang P, Tian Y, Xiao Y, et al. A metanephric adenoma of the kidney associated with polycythemia: a case report[J]. Oncol Lett, 2016, 11(1): 352-354.
[2] Moch H, Cubilla AL, Humphrey PA, et al. The 2016 WHO classification of tumours of the urinary system and male genital organs-part A: renal, penile, and testicular tumours[J]. Eur Urol, 2016, 70(1): 93-105.
[3] Kuroda N, Tol M, Hiroi M, et al. Review of metanephric adenoma of the kidney with focus on clinical and pathobiological aspects[J]. Histol Histopathol, 2003, 18(1): 253-257.
[4] Bove KE, Bhathena D, Wyatt RJ, et al. Diffuse metanephric adenoma after in utero aspirin intoxication. A unique case of progressive renal failure[J]. Arch Pathol Lab Med, 1979, 103(4): 187-190.
[5] Brisigotti M, Cozzutto C, Fabbretti G, et al. Metanephric adenoma[J]. Histol Histopathol, 1992, 7(4): 689-692.
[6] Davis CJ, Barton JH, Sesterhenn IA, et al. Metanephric adenoma. Clinicopathological study of fifty patients[J]. Am J Surg Pathol, 1995, 19(10): 1101-1114.
[7] Jones EC, Pins M, Dickersin GR, et al. Metanephric adenoma of the kidney. A clinicopathological, immunohistochemical, flow cytometric, cytogenetic, and electron microscopic study of seven cases[J]. Am J Surg Pathol, 1995, 19(6): 615-626.
[8] Yoshioka K, Miyakawa A, Ohno Y, et al. Production of erythropoietin and multiple cytokines by metanephric adenoma results in erythrocytosis[J]. Pathol Int, 2007, 57(8): 529-536.
[9] Dusan R, Relja K, Marija M, et al. A case of metanephric adenoma and acute myocardial infarction[J]. Acta Cardiol Sin, 2016, 32(4): 502-505.
[10] Zhang LJ, Yang GF, Shen W, et al. CT and ultrasound findings of metanephric adenoma: a report of two cases and literature review[J]. Br J Radiol, 2011, 84(999): e51-e54. doi: 10.1259/bjr/62994226.
[11] Zambrano N, Vivaldi B, Espinoza R. [Metanephric adenoma of the kidney associated with polycythemia and erythromelalgia: report of one case] [J]. Rev Med Chil, 2012, 140(5): 629-632.
[12] Yan J, Cheng JL, Li CF, et al. The findings of CT and MRI in patients with metanephric adenoma[J]. Diagn Pathol, 2016, 11(1):104.
[13] Jiang T, Li W, Lin D, et al. Imaging features of metanephric adenoma and their pathological correlation[J]. Clin Radiol, 2019, 74(5): 408-409.
[14] Sun Z, Kan S, Zhang L, et al. Immunohistochemical phenotype and molecular pathological characteristics of metanephric adenoma[J]. Int J Clin Exp Pathol, 2015, 8(6): 6031-6036.
[15] 席晨光, 范宇, 杨新宇, 等. 16例后肾腺瘤的临床病理特点及鉴别诊断[J]. 北京大学学报(医学版), 2016, 48(4): 598-602. XI Chenguang, FAN Yu, YANG Xinyu, et al. Clinicopathological features and differential diagnosis of metanephric adenoma: a report of sixteen cases[J]. Journal of Peking University(Health Sciences), 2016, 48(4): 598-602.
[16] Yakirevich E, Magi-Galluzzi C, Grada Z, et al. Cadherin 17 is a sensitive and specific marker for metanephric adenoma[J]. Am J Surg Pathol, 2015, 39(4): 479-486.
[17] Azabdaftari G, Alroy J, Banner BF, et al. S100 protein expression distinguishes metanephric adenomas from other renal neoplasms[J]. Pathol Res Pract, 2008, 204(10): 719-723.
[18] Olgac S, Hutchinson B, Tickoo SK, et al. Alpha-methylacyl-CoA racemase as a marker in the differential diagnosis of metanephric adenoma[J]. Mod Pathol, 2006, 19(2): 218-224.
[19] Kinney SN, Eble JN, Hes O, et al. Metanephric adenoma: the utility of immunohistochemical and cytogenetic analyses in differential diagnosis, including solid variant papillary renal cell carcinoma and epithelial-predominant nephroblastoma[J]. Mod Pathol, 2015, 28(9): 1236-1248.
[20] Le Nué R, Marcellin L, Ripepi M, et al. Conservative treatment of metanephric adenoma. A case report and review of the literature[J]. J Pediatr Urol, 2011, 7(4): 399-403.
[21] Delzongle M, Boukamel S, Kemeny F, et al. Metanephric adenoma: MR imaging features with histopathological correlation[J]. Diagn Interv Imaging, 2015, 96(4): 387-390.
[22] Drut R, Drut RM, Ortolani C. Metastatic metanephric adenoma with foci of papillary carcinoma in a child: a combined histologic, immunohistochemical, and FISH study[J]. Int J Surg Pathol, 2001, 9(3): 241-247.
[1] 赵立星 宋代辉 魏魁杰 殷恺. 颞下颌关节骨关节病动物模型的建立[J]. 山东大学学报(医学版), 2209, 47(6): 25-27.
[2] 李波波 李道堂 刘曙光 王兴武. 食管癌患者血清中DKK-1的表达[J]. 山东大学学报(医学版), 2209, 47(6): 58-61.
[3] 徐平 于国放 李霞. 不同类型甲状腺上动脉PSV对Graves病与桥本氏甲状腺炎鉴别诊断的价值[J]. 山东大学学报(医学版), 2209, 47(6): 62-64.
[4] 王欣,邢春燕,杨艳平. 血清磷酸丙酮酸水合酶检测对诊断侵袭性白念珠菌感染的临床价值[J]. 山东大学学报(医学版), 2209, 47(6): 92-94.
[5] 巩性军,吴树明,张供,李守先,庞昕焱. 无顶冠状静脉窦综合征的诊断和外科治疗[J]. 山东大学学报(医学版), 2209, 47(6): 129-.
[6] 孙文雄,吴日超,郑贤静,李丽, 张友忠. 宫颈血管周上皮样细胞肿瘤1例[J]. 山东大学学报 (医学版), 2022, 60(9): 125-128.
[7] 吴瑞芳,李长忠. 女性生育力保护的现状与进展[J]. 山东大学学报 (医学版), 2022, 60(9): 1-7.
[8] 王丽慧,高敏,孔北华. 子宫血管肉瘤2例报告并文献复习[J]. 山东大学学报 (医学版), 2022, 60(9): 108-112.
[9] 韩靖,贾春玲. 肺癌患者胸外手术前治疗牙周基础疾病对预防术后肺炎发生的效果评价[J]. 山东大学学报 (医学版), 2022, 60(9): 113-118.
[10] 王文静,刘博策,毕见海,霍然. 超声引导下平阳霉素联合聚桂醇硬化治疗94例囊性淋巴管畸形的疗效[J]. 山东大学学报 (医学版), 2022, 60(8): 72-78.
[11] 彭超,周应芳. 子宫腺肌病的药物治疗进展[J]. 山东大学学报 (医学版), 2022, 60(7): 20-25.
[12] 秦静,杨飞,陈谦,夏涵岱,刘延国,王秀问. 晚期驱动基因阴性、PD-L1表达阴性非鳞非小细胞肺癌一线治疗方案的网状Meta分析[J]. 山东大学学报 (医学版), 2022, 60(7): 74-82.
[13] 王福立,孙银萍,秦杰,荣建胜. DC-CIK细胞联合EGFR-TKI治疗35例老年晚期EGFR突变肺癌的效果[J]. 山东大学学报 (医学版), 2022, 60(7): 110-117.
[14] 查菁,郭婧,左秀丽. 少见类型肠梗阻病因病例报告1例并文献复习[J]. 山东大学学报 (医学版), 2022, 60(6): 130-132.
[15] 王菊,高帅,范玉琛,王凯. 肝衰竭并发真菌感染综合治疗1例[J]. 山东大学学报 (医学版), 2022, 60(5): 125-128.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!